Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Lossignol

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Revue Medicale De Bruxelles|December 24, 2010
[Do-Not-Resuscitate Orders in intensive care]Dominique Lossignol
Current Opinion in Oncology|February 22, 2019
Cannabinoids: a new approach for pain control?Dominique Lossignol
Journal of Translational Internal Medicine|February 14, 2017
A little help from steroids in oncologyDominique Lossignol
Current Opinion in Oncology|April 19, 2015
End-of-life sedation: is there an alternative?Dominique Lossignol
Current Opinion in Oncology|May 21, 2014
Narrative ethics in the field of oncologyDominique Lossignol
The European Respiratory Journal|October 2, 2012
Euthanasia: from ethical debate to clinical realityThierry Berghmans, Dominique Lossignol
Case Reports in Oncological Medicine|February 21, 2013
Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the LiteratureCristina Dumitrescu, Dominique Lossignol
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2015
Supportive/palliative care in cancer patients: quo vadis?Jean Klastersky, Isabelle Libert, Bénédicte Michel, et al.
Journal of Pain and Symptom Management|November 13, 2012
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesicsJeremy R Johnson, Dominique Lossignol, Mary Burnell-Nugent, et al.
Anti-Cancer Drugs|November 1, 2006
Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalpBernd Kasper, Dominique Lossignol, Thierry Gil, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Revue Medicale De Bruxelles|December 24, 2010
[Do-Not-Resuscitate Orders in intensive care]Dominique Lossignol
Current Opinion in Oncology|February 22, 2019
Cannabinoids: a new approach for pain control?Dominique Lossignol
Journal of Translational Internal Medicine|February 14, 2017
A little help from steroids in oncologyDominique Lossignol
Current Opinion in Oncology|April 19, 2015
End-of-life sedation: is there an alternative?Dominique Lossignol
Current Opinion in Oncology|May 21, 2014
Narrative ethics in the field of oncologyDominique Lossignol
The European Respiratory Journal|October 2, 2012
Euthanasia: from ethical debate to clinical realityThierry Berghmans, Dominique Lossignol
Case Reports in Oncological Medicine|February 21, 2013
Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the LiteratureCristina Dumitrescu, Dominique Lossignol
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2015
Supportive/palliative care in cancer patients: quo vadis?Jean Klastersky, Isabelle Libert, Bénédicte Michel, et al.
Journal of Pain and Symptom Management|November 13, 2012
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesicsJeremy R Johnson, Dominique Lossignol, Mary Burnell-Nugent, et al.
Anti-Cancer Drugs|November 1, 2006
Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalpBernd Kasper, Dominique Lossignol, Thierry Gil, et al.
Pageof 2